The Ametris Connect™ Platform And Real-World Applications

The modern clinical landscape demands a shift from intermittent snapshots to a continuous collection of high-precision digital health data. By integrating medical-grade sensors—including ECG patches, spirometers, and actigraphy—into a device-agnostic ecosystem, the Ametris Connect platform provides the high-precision data necessary to modernize clinical outcome measures. This approach is particularly transformative for oncology and immunology researchers, where AI-powered algorithms can monitor for early indicators of adverse events like cytokine release syndrome (CRS), improving both patient safety and trial cost-effectiveness. By utilizing an extensive library of digital biomarkers and validated endpoints, study teams can capture subtle physiological shifts across decentralized, hybrid, or traditional models. The platform simplifies these complex transitions by combining remote data capture with intuitive tools, reducing participant burden while boosting retention. Ultimately, this unified ecosystem turns raw digital signals into regulatory-ready evidence, offering the operational and analytical framework required to accelerate therapeutic innovation and streamline study design.